1887

Chapter 45 : Diagnosis of Infection and Assessment of Eradication

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Diagnosis of Infection and Assessment of Eradication, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH45-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH45-2.gif

Abstract:

is a Gram-negative, microaerophilic spiral bacterium which is recognized as the primary cause of chronic gastritis in humans. Untreated infection precedes and is required for the development of most cases of gastric and duodenal ulcers (1, 2). Further, infection substantially increases the risk of development of gastric cancer in some populations. Following the discovery and identification of as a significant human pathogen, it is now recognized as probably the most common bacterial infection of humankind, infecting approximately 50% of the world's population. Specific antibiotics combined with proton pump inhibitors are now routinely used to treat and eliminate previously chronic gastroduodenal diseases. For their novel work in helping us to understand the critical role played by in peptic ulcer disease, Robin Warren and Barry Marshall were awarded the Nobel Prize in Physiology or Medicine in 2005.

Citation: Dunn B, Phadnis S. 2016. Diagnosis of Infection and Assessment of Eradication, p 404-411. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch45
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818722.ch45
1. Makola D, Peura DA, Crowe SE. 2007. Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 41:548558.[CrossRef].[PubMed]
2. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ European Helicobacter Study Group. 2012. Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report. Gut 61:646664.[CrossRef].[PubMed]
3. Chey WD, Wong BC Practice Parameters Committee of the American College of Gastroenterology. 2007. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102:18081825.[CrossRef].[PubMed]
4. Malfertheiner P, Selgard M. 2010. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol 26:618623.[CrossRef].[PubMed]
5. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A 96:1455914564.[PubMed].[CrossRef]
6. Sokic-Milutinovi T, Wex T, Todorovic V, Milosavljevic T, Malfertheiner P. 2004. Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro. Scand J Gastroenterol 3:222226.
7. Wu M, Chow L, Lin J, Chiou S. 2008. Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities. J Gastroenterol Hepatol 23:16571661.[CrossRef].[PubMed]
8. McNulty CAM, Lehours P, Megraud F. 2011. Diagnosis of Helicobacter pylori infection. Helicobacter 16:1018.[CrossRef].[PubMed]
9. Tonkic A, Tonkic M, Lehours P, Megraud F. 2012. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 17:18.[CrossRef].[PubMed]
10. Camorlinga-Ponce M, Romo C, Gonzalez-Valencia G, Munoz O, Torres J. 2004. Topographical localization of cagA positive and cagA negative Helicobacter pylori strains in the mucosa: an in situ hybridization study. J Clin Pathol 57:822828.[CrossRef].[PubMed]
11. Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Kagaya H, Hokari K, Asaka M. 2000. A prospective evaluation of new rapid urease tests before and after eradication treatment of Helicobacter pylori, in comparison with histology, culture and 13C-urea breath test. Gastrointest Endosc 51:164168.[PubMed].[CrossRef]
12. Windsor HM, Abioye-Kutey EA, Marshall BJ. 2005. Methodology and transport medium for collection of Helicobacter pylori on a string test in remote location. Helicobacter 10:630634.[CrossRef].[PubMed]
13. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, El-Zimaity HM. 2003. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 98:10051009.[CrossRef].[PubMed]
14. Veijola L, Myllyluoma E, Korpela R, Rautelin H. 2005. Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy. World J Gastroenterol 11:73407344.[PubMed].[CrossRef]
15. Wu DC, Wu IC, Wang SW, Lu CY, Ke HL, Yuan SS, Wang YY, Chang WH, Wang TE, Bair MJ, Ku FC. 2006. Comparison of stool enzyme immunoassay and immunochromatographic method for detecting Helicobacter pylori antigens before and after eradication. Diagn Microbiol Infect Dis 56:373378.[CrossRef].[PubMed]
16. Bergy B, Marchildon P, Peacock J, Megraud F. 2003. What is the role of serology in assessing Helicobacter pylori eradication? Aliment Pharmacol Ther 18:635639.[CrossRef]
17. Hoang TT, Wheeldon TU, Bengtsson C, Phung DC, Sorberg M, Granstrom M. 2004. Enzyme-linked immunosorbent assay for Helicobacter pylori needs adjustment for the population investigated. J Clin Microbiol 42:627630.[PubMed].[CrossRef]
18. Krah A, Miehlke S, Pleissner KP, Zimny-Arndt U, Kirsch C, Lehn N, Meyer TF, Jungblut PR, Aebischer T. 2004. Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer 108:456463.[CrossRef].[PubMed]
19. Perez-Perez GI, Peek RM, Atherton JC, Blaser MJ, Cover TL. 1999. Detection of anti-VacA antibody response in serum and gastric juice samples using types 1/ma and s2/m2 Helicobacter pylori VacA antigens. Clin Diagn Lab Immunol 6:489493.[PubMed]
20. Megraud F, Lehours P. 2007. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 20:280322.[CrossRef].[PubMed]
21. Leal YA, Flores LL, Garcia-Cortes LB, Cedillo-Rivera R, Torres J. 2008. Antibody-based detection tests for the diagnosis of Helicobacter pylori infection in children: a meta-analysis. PLoS One 3:e3751.[CrossRef].[PubMed]
22. Shimizu T, Yarita Y, Haruna H, Kaneko K, Yamashiro Y, Gupta R, Anazawa A, Suzuki K. 2003. Urine-based enzyme-linked immunosorbent assay for the detection of Helicobacter pylori antibodies in children. J Paediatr Child Health 39:606610.[PubMed].[CrossRef]
23. Monteiro L, Bergey B, Gras N, Megraud F. 2002. Evaluation of the performance of the Helico Blot 2.1 as a tool to investigate the virulence properties of Helicobacter pylori. Clin Microbiol Infect 8:676679.[PubMed].[CrossRef]
24. Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, Graham DY, Yamaoka Y. 2002. New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol 40:47534756.[PubMed].[CrossRef]
25. Kobayashi D, Eishi Y, Ohkusa T, Ishige T, Suzuki T, Minami J, Yamada T, Takizawa T, Koike M. 2002. Gastric mucosal density of Helicobacter pylori estimated by real-time PCR compared with results of urea breath test and histological grading. J Med Microbiol 51:305311.[CrossRef].[PubMed]
26. Chisholm SA, Teare EL, Patel B, Owen RJ. 2002. Determination of Helicobacter pylori VacA allelic types by single-step multiplex PCR. Lett Appl Microbiol 35:4246.[PubMed].[CrossRef]
27. Hao Q, Li Y, Zhang ZJ, Liu Y, Gao H. 2004. New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. World J Gastroenterol 10:10751077.[PubMed]
28. Oleastro M, Menard A, Santos A, Lamouliatte H, Monteiro L, Barthelemy P, Megraud F. 2003. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol 41:397402.[PubMed].[CrossRef]
29. Kabir S. 2004. Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review. Helicobacter 9:115123.[CrossRef].[PubMed]
30. Selgrad M, Malfertheiner P. 2011. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 27:565570.[CrossRef].[PubMed]
31. Crone J, Gold BD. 2004. Helicobacter pylori infection in pediatrics. Helicobacter 9(Suppl 1):4956.[CrossRef].[PubMed]
32. Leal YA, Flores LL, Fuentes-Panana EM, Cedillo-Rivera R, Torres J. 2011. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a systematic review and meta-analysis. Helicobacter 16: 327337.[CrossRef].[PubMed]
33. Moya DA, Crissinger KD. 2012. Helicobacter pylori persistence in children: distinguishing inadequate treatment, resistant organisms, and reinfection. Curr Gastroenterol Rep 14:236242.[CrossRef].[PubMed]

Tables

Generic image for table
TABLE 1

Overview of diagnostic tests for detection of

Citation: Dunn B, Phadnis S. 2016. Diagnosis of Infection and Assessment of Eradication, p 404-411. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch45

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error